Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 11, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acelyrin, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Sagimet Biosciences Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Progyny, Inc.
| 7.21K |
—
|
—
| +19.90% | 43.42K |
May 23
| |||||||
Vera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 15
| |||||||
Kyverna Therapeutics, Inc.
| 4.52M |
—
|
—
|
∞
| 4.52M |
Feb 12
| |||||||
Kyverna Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sagimet Biosciences Inc.
| 1.99M |
$16.00 | $750,000.00 | +5,139.84% | 2.03M |
Jul 18
| |||||||
Sagimet Biosciences Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Progyny, Inc.
| -6.88K |
—
|
—
| -15.96% | 36.21K |
Jun 23
| |||||||
Progyny, Inc.
| -1.38M |
—
|
—
| -21.18% | 5.12M |
Jun 9
| |||||||
Atara Biotherapeutics, Inc.
| 57K |
—
|
—
| +97.12% | 115.69K |
May 31
| |||||||
Progyny, Inc.
| 5.12K |
—
|
—
| +36.15% | 19.27K |
May 24
| |||||||
Vera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 10
| |||||||
Acelyrin, Inc.
| 9.85M |
$18.00 | $1,080,000.00 |
∞
| 9.85M |
May 9
| |||||||
Acelyrin, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 4
| |||||||
Acelyrin, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Vera Therapeutics, Inc.
| 2.3K |
$7.24 | $16,650.85 | +0.12% | 1.95M |
Mar 30
| |||||||
Vera Therapeutics, Inc.
| 23.91K |
$7.24 | $173,191.94 | +1.24% | 1.95M |
Mar 28
| |||||||
Vera Therapeutics, Inc.
| 3.47K |
$7.24 | $25,102.11 | +0.18% | 1.92M |
Mar 24 - Mar 27
| |||||||
Vera Therapeutics, Inc.
| 89.3K |
$7.13 | $636,914.51 | +4.88% | 1.92M |
Mar 17 - Mar 20
| |||||||
Vera Therapeutics, Inc.
| 92.94K |
$7.10 | $660,278.24 | +5.35% | 1.83M |
Mar 15 - Mar 16
| |||||||
Vera Therapeutics, Inc.
| 48K |
$7.16 | $343,485.47 | +2.84% | 1.74M |
Mar 10
| |||||||
Vera Therapeutics, Inc.
| 1K |
$7.25 | $7,245.00 | +0.06% | 1.69M |
Mar 3
| |||||||
Vera Therapeutics, Inc.
| 23.48K |
$7.24 | $170,047.18 | +1.41% | 1.69M |
Mar 1 - Mar 2
| |||||||
Vera Therapeutics, Inc.
| 200 |
$7.24 | $1,447.00 | +0.01% | 1.66M |
Feb 23
| |||||||
Vera Therapeutics, Inc.
| 10.07K |
$7.20 | $72,490.20 | +0.61% | 1.66M |
Feb 13
| |||||||
Vera Therapeutics, Inc.
| 400 |
$7.25 | $2,900.00 | +0.02% | 1.65M |
Feb 9
| |||||||
Vera Therapeutics, Inc.
| 311.08K |
$7.10 | $2,209,588.20 | +23.16% | 1.65M |
Feb 3 - Feb 8
| |||||||
Progyny, Inc.
| 4.06K |
—
|
—
| +1.71% | 242.06K |
Mar 3 - Oct 24
| |||||||
Atara Biotherapeutics, Inc.
| 20.5K |
—
|
—
| +53.68% | 58.69K |
Jun 23
| |||||||
Vera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Progyny, Inc.
| -4.01K |
—
|
—
| -10.82% | 33.09K |
Dec 22
| |||||||
Progyny, Inc.
| -905.59K |
—
|
—
| -12.21% | 6.51M |
Nov 17
| |||||||
Progyny, Inc.
| -29.71K |
—
|
—
| -74.64% | 10.09K |
Sep 16 - Oct 24
| |||||||
Progyny, Inc.
| -8.50K |
—
|
—
| -17.60% | 39.8K |
Jul 19
| |||||||
Progyny, Inc.
| -1.36M |
—
|
—
| -15.11% | 7.63M |
May 27 - Jun 21
| |||||||
Atara Biotherapeutics, Inc.
| 11K |
—
|
—
| +40.46% | 38.19K |
Jun 8
| |||||||
Vera Therapeutics, Inc.
| 1.34M |
—
|
—
|
∞
| 1.34M |
May 18
| |||||||
Vera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Vera Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.